Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Uzuka

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
The Tohoku Journal of Experimental Medicine|April 1, 1983
Treatment of acute lymphoblastic leukemia in adults with combination chemotherapy incorporating vindesine and prednisoloneY Saito, Y Uzuka
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Clinical trials of bestatin for leukemia and solid tumorsK Ota, Y Uzuka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1989
[Bestatin treatment of patients with myelodysplastic syndromes]Y Uzuka, Y Saito
Cancer Treatment Reports|November 1, 1985
Treatment of chronic myelogenous leukemia in blastic crisis with chemotherapy incorporating vindesine-prednisoloneY Uzuka, Y Saito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Individualized chemotherapy of adult acute nonlymphocytic leukemia]Y Uzuka, Y Saito
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 1, 1989
[The curative treatment of adult acute nonlymphocytic leukemia]Y Uzuka, Y Saito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1991
[Combination therapy of chronic myelogenous leukemia with busulfan and bestatin]Y Uzuka, Y Saito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Treatment of myelodysplastic syndrome using SM-108 in relation to stem cell kinetics]Y Uzuka, Y Saito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1993
[Bestatin therapy of chronic myelogenous leukemia]Y Uzuka, Y Saito
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Bestatin treatment of myelodysplastic syndromes (MDS) and the effects of bestatin on hematopoiesis in MDSY Uzuka, Y Saito
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
The Tohoku Journal of Experimental Medicine|April 1, 1983
Treatment of acute lymphoblastic leukemia in adults with combination chemotherapy incorporating vindesine and prednisoloneY Saito, Y Uzuka
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Clinical trials of bestatin for leukemia and solid tumorsK Ota, Y Uzuka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1989
[Bestatin treatment of patients with myelodysplastic syndromes]Y Uzuka, Y Saito
Cancer Treatment Reports|November 1, 1985
Treatment of chronic myelogenous leukemia in blastic crisis with chemotherapy incorporating vindesine-prednisoloneY Uzuka, Y Saito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Individualized chemotherapy of adult acute nonlymphocytic leukemia]Y Uzuka, Y Saito
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 1, 1989
[The curative treatment of adult acute nonlymphocytic leukemia]Y Uzuka, Y Saito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1991
[Combination therapy of chronic myelogenous leukemia with busulfan and bestatin]Y Uzuka, Y Saito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Treatment of myelodysplastic syndrome using SM-108 in relation to stem cell kinetics]Y Uzuka, Y Saito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1993
[Bestatin therapy of chronic myelogenous leukemia]Y Uzuka, Y Saito
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Bestatin treatment of myelodysplastic syndromes (MDS) and the effects of bestatin on hematopoiesis in MDSY Uzuka, Y Saito
Pageof 8